Blepharospasm (DBCOND0001075)

Identifiers

Synonyms
Blepharal spasm / Blepharospasm (disorder) / Spasm eyelid / Eyelid twitching

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Botulinum toxin type A
A purified form of botulinum toxin type A used to block acetylcholine release in the treatment of chronic sialorrhea, muscle spasticity, and dystonia, as well as in cosmetic applications.
Clostridium botulinum
Not Annotated
No drug targets
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05103202
Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum ToxinNo drug interventionsNot AvailableNot Availablecompleted
NCT00001784
Mexiletine for the Treatment of Focal Dystoniatreatment2completed
NCT04618887
A Comparative Study of GPI's DBS and Pallidotomy in the Treatment of Meige SyndromeNo drug interventionsNot AvailableNot Availableunknown_status
NCT01287247
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United StatesNot AvailableNot Availablecompleted
NCT01546805
Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial SpasmtreatmentNot Availableunknown_status
NCT03184597
HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse ReactionsNo drug interventionspreventionNot Availableunknown_status
NCT05027997
Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasmtreatment2unknown_status
NCT04939909
Botulinum Toxin Relieves Anxiety, Depression and Sleep Disorderes in Patients With Blepharospasmtreatment0unknown_status
NCT02947815
Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasmtreatment2 / 3completed
NCT03263000
Photic Blink Reflex in People With Blepharospasm and Increased BlinkingNo drug interventionsNot AvailableNot Availableterminated
NCT00500799
Brain Changes in BlepharospasmNo drug interventionsNot AvailableNot Availablecompleted
NCT02780336
Blepharospasm ToolsNo drug interventionsNot AvailableNot Availablecompleted
NCT04423341
Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasmtreatment2 / 3completed
NCT01814774
A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and BlepharospasmNo drug interventionsNot AvailableNot Availablecompleted
NCT03269123
A Mechanical Device for BlepharospasmNo drug interventionstreatmentNot Availablecompleted
NCT00535938
MDs on Botox Utility (MOBILITY)No drug interventionsNot AvailableNot Availablecompleted
NCT01686061
Blepharospasm Patient Survey for Patients With BlepharospasmNo drug interventionsNot AvailableNot Availablecompleted
NCT02327728
Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of BlepharospasmtreatmentNot Availableunknown_status
NCT00234507
Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasmtreatment2completed
NCT00507637
Blepharospasm Short Intervaltreatment2terminated
NCT05618470
Wumeiwan Jiawei Fang Use in Patients With Blepharospasmtreatment2 / 3recruiting
NCT02765113
Two Different Surgical Methods of BlepharospasmNo drug interventionstreatment0unknown_status
NCT02577224
An RCT of a Patient-initiated Treatment Service for BEB and HFSNo drug interventionshealth_services_researchNot Availablecompleted
NCT02245958
A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and BlepharospasmNo drug interventionsNot AvailableNot Availablecompleted
NCT03938363
Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal DystoniaNo drug interventionsbasic_scienceNot Availablecompleted
NCT03508882
Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasmtreatment4completed
NCT00210431
Post Marketing Surveillance Study of DysportNo drug interventionsNot AvailableNot Availablecompleted
NCT00682760
Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasmtreatment3completed
NCT00761592
Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasmtreatment4completed
NCT00406367
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasmtreatment3completed
NCT00411255
Brain Stimulation to Treat Blepharospasm or Meige SyndromeNo drug interventionssupportive_care2completed
NCT04755192
Data Analysis of Protocol 04-N-0188: Neurophysiological Markers in Patients With Craniofacial Dystonia and Their RelativesNo drug interventionsNot AvailableNot Availableactive_not_recruiting